07/13 StreetInsider.com Unusual 11 Mid-Day Movers

Sento Corp. (Nasdaq: SNTO) 49% LOWER; Expects to report consolidated revenues in the range of $14.4 to $14.6 million, an operating loss of $1.5 to $1.6 million and a net loss in the range of $1.4 to $1.5 million or $0.36 to $0.38 per diluted share for the fiscal 2007 first quarter. The Company had originally expected revenues to approach $16 million and that it would maintain operating profitability in the fiscal 2007 first quarter.

Multi-Fineline Electronix (Nasdaq: MFLX) 22% LOWER; Currently expects its net income for Q3 to be between $7.5-$8.5 million. On May 9, 2006, the company estimated earnings to be in the range of $12.2-$13.6 million M-Flex confirmed its earlier revenue guidance of between $126.0-$136.0 million.

Cree, Inc. (Nasdaq: CREE) 22% LOWER; Company said based on preliminary financial results, revenue for the fourth quarter ended June 25, 2006, is expected to be approximately $106.7 million, versus the consensus of $107.32 million. The company also said earnings will be below the company's previously announced target range of $0.22 to $0.24 per diluted share. The EPS consensus is $0.23.

Nastech Pharmaceutical (Nasdaq: NSTK) 18.8% LOWER; Notification from the FDA was received on July 10, 2006 stating that Nastech's abbreviated new drug application (ANDA) for intranasal calcitonin-salmon is not approvable at this time.

Warner Music Group (NYSE: WMG) 17.3% LOWER; A European Court overturned the European Commission's approval for the merger between Warner Music and EMI. The Company stated: We are in the process of reviewing today's decision by the European Court of First Instance regarding Sony BMG to determine what impact it might have on a potential combination of Warner Music Group and EMI Group plc.

Schiff Nutrition Int'l (formerly Weider Nutrition Int'l) (NYSE: WNI) 9.9% HIGHER; Company reports Q4 EPS of $0.23 compared to a loss of $0.07 from the same period a year ago. Net sales for Q4 were $45.3 million compared to $39.9 million for the same period in fiscal 2005.

Corautus Genetics (Nasdaq: VEGF) 9.52% HIGHER; Company announced that the FDA has recently lifted the clinical hold imposed March 29, 2006 on its GENASIS Phase IIb clinical trial for the treatment of cardiovascular (severe angina) disease.

GameStop Corp. (NYSE: GME) 7.2% HIGHER; Multimedia & Graphics Software sector moving higher. Also, the stock has fallen approx. 20% since May 5th, 2006.

Flow Int'l (Nasdaq: FLOW) 6.8% HIGHE; Company reported preliminary Q4 EPS of $0.19, 7 cents better than estimates.(0.12) Revenues were $63.3 million vs. $56.45 million consensus.

SAP AG (NYSE: SAP) 6.7% LOWER; Announces 2006 Second Quarter Preliminary Results. The company warned that it expects second quarter 2006 software revenues to be approximately 621 million euros, representing an increase of 8%. Analyst were looking for 675 million euros.

Administaff (NYSE: ASF) 4.2% HIGHER; JMP Securities Upgrades ASF to Market Outperform

You May Also Be Interested In

• Barclays sees music streaming growth narrow gap with Spotify
• Jefferies: US equity ETF inflows jump to $27.8B on strong demand
• Array shifts to integrated solar platform with record orderbook